Article info
Therapeutics
Budesonide increased remission rates more than mesalamine in active Crohn disease
Citation
Budesonide increased remission rates more than mesalamine in active Crohn disease
Online issue publication
April 01, 1999
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions